EXP6155

Known as: 1H-Imidazole-5-acetic acid, 2-butyl-1-((4-carboxyphenyl)methyl)-4-chloro-, disodium salt, EXP 6155, EXP-6155 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-1991
01219891991

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1991
Review
1991
Some simple N-benzylimidazoles, originally described by Takeda Chemical Industries (Osaka, Japan), were characterized to be very… (More)
Is this relevant?
Review
1990
Review
1990
The most direct approach to block the function of the renin-angiotensin system would be to antagonize angiotensin II (AII) at the… (More)
Is this relevant?
1989
1989
EXP6155 (2-n-butyl-1-[4-carboxybenzyl]-4-chloroimidazole-5-acetic acid) and EXP6803 (methyl 2-n-butyl-1-[4-(2-carboxybenzamido… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
1989
1989
A series of 1-benzylimidazole-5-acetate derivatives defining the critical substituents on the phenyl ring was synthesized in… (More)
Is this relevant?